LCM
IOVA icon

Legato Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Legato Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.3K Sell
16,885
-1,593
-9% -$5.09K 0.01% 709
2025
Q4 		$50.4K Buy
18,478
+1,619
+10% +$3.75K ﹤0.01% 739
2025
Q3 		$36.6K Hold
16,859
– – ﹤0.01% 554
2025
Q2 		$29K Sell
16,859
-221
-1% -$550 ﹤0.01% 560
2025
Q1 		$56.9K Sell
17,080
-1,138
-6% -$5.87K 0.01% 540
2024
Q4 		$135K Hold
18,218
– – 0.02% 530
2024
Q3 		$171K Hold
18,218
– – 0.02% 528
2024
Q2 		$146K Buy
18,218
+131
+0.7% +$1.4K 0.02% 528
2024
Q1 		$268K Hold
18,087
– – 0.03% 515
2023
Q4 		$147K Buy
18,087
+642
+4% +$3.36K 0.02% 540
2023
Q3 		$79.4K Buy
+17,445
New +$114K 0.01% 534

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return